TLPH
Price
$0.49
Change
-$0.02 (-3.92%)
Updated
Jun 13 closing price
Capitalization
17.48M
TXMD
Price
$1.17
Change
-$0.03 (-2.50%)
Updated
Jun 13 closing price
Capitalization
24.32M
65 days until earnings call
Interact to see
Advertisement

TLPH vs TXMD

Header iconTLPH vs TXMD Comparison
Open Charts TLPH vs TXMDBanner chart's image
Talphera
Price$0.49
Change-$0.02 (-3.92%)
Volume$8.35K
Capitalization17.48M
TherapeuticsMD
Price$1.17
Change-$0.03 (-2.50%)
Volume$13.97K
Capitalization24.32M
TLPH vs TXMD Comparison Chart
Loading...
TLPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TXMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TLPH vs. TXMD commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TLPH is a Hold and TXMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (TLPH: $0.49 vs. TXMD: $1.17)
Brand notoriety: TLPH and TXMD are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: TLPH: 24% vs. TXMD: 27%
Market capitalization -- TLPH: $17.48M vs. TXMD: $24.32M
TLPH [@Pharmaceuticals: Other] is valued at $17.48M. TXMD’s [@Pharmaceuticals: Other] market capitalization is $24.32M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TLPH’s FA Score shows that 0 FA rating(s) are green whileTXMD’s FA Score has 0 green FA rating(s).

  • TLPH’s FA Score: 0 green, 5 red.
  • TXMD’s FA Score: 0 green, 5 red.
According to our system of comparison, TXMD is a better buy in the long-term than TLPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TLPH’s TA Score shows that 3 TA indicator(s) are bullish while TXMD’s TA Score has 3 bullish TA indicator(s).

  • TLPH’s TA Score: 3 bullish, 5 bearish.
  • TXMD’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, TLPH is a better buy in the short-term than TXMD.

Price Growth

TLPH (@Pharmaceuticals: Other) experienced а -3.92% price change this week, while TXMD (@Pharmaceuticals: Other) price change was -6.40% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.40%. For the same industry, the average monthly price growth was +14.50%, and the average quarterly price growth was +66.97%.

Reported Earning Dates

TXMD is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.40% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TXMD($24.3M) has a higher market cap than TLPH($17.5M). TXMD YTD gains are higher at: 36.047 vs. TLPH (-6.506). TXMD has higher annual earnings (EBITDA): 52.6M vs. TLPH (-9.84M). TXMD has more cash in the bank: 10.2M vs. TLPH (9.38M). TXMD has higher revenues than TLPH: TXMD (69.4M) vs TLPH (651K).
TLPHTXMDTLPH / TXMD
Capitalization17.5M24.3M72%
EBITDA-9.84M52.6M-19%
Gain YTD-6.50636.047-18%
P/E RatioN/A0.47-
Revenue651K69.4M1%
Total Cash9.38M10.2M92%
Total DebtN/A8.2M-
FUNDAMENTALS RATINGS
TLPH vs TXMD: Fundamental Ratings
TLPH
TXMD
OUTLOOK RATING
1..100
554
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9892
PRICE GROWTH RATING
1..100
8354
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TXMD's Valuation (50) in the Pharmaceuticals Generic industry is somewhat better than the same rating for TLPH (95) in the Pharmaceuticals Other industry. This means that TXMD’s stock grew somewhat faster than TLPH’s over the last 12 months.

TXMD's Profit vs Risk Rating (100) in the Pharmaceuticals Generic industry is in the same range as TLPH (100) in the Pharmaceuticals Other industry. This means that TXMD’s stock grew similarly to TLPH’s over the last 12 months.

TXMD's SMR Rating (92) in the Pharmaceuticals Generic industry is in the same range as TLPH (98) in the Pharmaceuticals Other industry. This means that TXMD’s stock grew similarly to TLPH’s over the last 12 months.

TXMD's Price Growth Rating (54) in the Pharmaceuticals Generic industry is in the same range as TLPH (83) in the Pharmaceuticals Other industry. This means that TXMD’s stock grew similarly to TLPH’s over the last 12 months.

TXMD's P/E Growth Rating (100) in the Pharmaceuticals Generic industry is in the same range as TLPH (100) in the Pharmaceuticals Other industry. This means that TXMD’s stock grew similarly to TLPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TLPHTXMD
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
63%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 26 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
TLPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TXMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RYTM62.90-0.12
-0.19%
Rhythm Pharmaceuticals
ALCO31.26-0.28
-0.89%
Alico
VITL31.65-0.54
-1.68%
Vital Farms
DD66.87-1.57
-2.29%
DuPont de Nemours
IGC0.30-0.01
-3.23%
IGC Pharma

TLPH and

Correlation & Price change

A.I.dvisor tells us that TLPH and LVZPF have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPH and LVZPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLPH
1D Price
Change %
TLPH100%
-3.64%
LVZPF - TLPH
31%
Poorly correlated
N/A
TXMD - TLPH
25%
Poorly correlated
-2.50%
OPTN - TLPH
23%
Poorly correlated
N/A
RDY - TLPH
22%
Poorly correlated
-2.29%
HROW - TLPH
22%
Poorly correlated
-2.73%
More

TXMD and

Correlation & Price change

A.I.dvisor tells us that TXMD and ASRT have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TXMD and ASRT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TXMD
1D Price
Change %
TXMD100%
-2.50%
ASRT - TXMD
27%
Poorly correlated
+2.43%
TLPH - TXMD
25%
Poorly correlated
-3.64%
TLRY - TXMD
25%
Poorly correlated
-2.95%
SCYX - TXMD
24%
Poorly correlated
-1.76%
RMTI - TXMD
22%
Poorly correlated
-3.27%
More